Abstract
Purpose
Preserving renal function and controlling oncological outcomes are pertinent while managing renal tumours. We compared outcomes of percutaneous cryoablation (PCA) and retroperitoneoscopic cryoablation (RCA) in patients with renal neoplasms.
Methods
We identified 108 patients with renal tumours at two medical centres, where 63 patients received PCA and 45 patients underwent RCA from August 2009 to July 2015, and they were followed up until February 2017. We compared preoperative and postoperative parameters, namely gender, systemic diseases, age, American Society of Anesthesiologists score, body mass index (BMI), haemoglobin, the estimated glomerular filtration rate, tumour size, operative time, tumour type, Clavien–Dindo classification of surgical complications, and tumour recurrence, by using an independent sample t test, Pearson’s Chi-square test, Fisher’s exact test, a Mann–Whitney test, and a generalised linear model.
Results
Based on baseline characteristics, we found that the patients in the PCA group were older and had higher BMI than those in the RCA group, whereas the patients in the RCA group had more comorbidities than those in the PCA group. Retroperitoneoscopic and percutaneous methods had similar operative times, blood transfusion rates, postoperative fever episodes, and complication rates for either minor or major complications. However, the percutaneous method was associated with a shorter length of stay. No patient experienced deterioration in renal function until 2 years after both procedures. Impaired renal function was found in both groups in the 3-year follow-up. In both groups, tumour recurrence was significant for tumours > 4 cm.
Conclusions
Our results confirm that both cryoablation methods (PCA and RCA) are safe and effective for renal cell carcinoma. Favourable oncological control was achieved in both groups if the renal tumour size was ≤ 4 cm.
Similar content being viewed by others
Change history
18 September 2018
In the original publication, Prof. Lin-Nei Hsu’s institution was incorrectly published as ‘Tainan Municipal An-Nan Hospital’ in affiliation 4. The correct affiliation should read as ‘Department of Urology, An-Nan Hospital, China Medical University, Tainan, Taiwan’.
References
Kane CJ et al (2008) Renal cell cancer stage migration: analysis of the National Cancer Data Base. Cancer 113(1):78–83
Sahni VA, Silverman SG (2014) Imaging management of incidentally detected small renal masses. Semin Interv Radiol 31(1):9–19
Remzi M, Javadli E, Ozsoy M (2010) Management of small renal masses: a review. World J Urol 28(3):275–281
Volpe A et al (2011) Contemporary management of small renal masses. Eur Urol 60(3):501–515
Jewett MAS et al (2015) Canadian guidelines for the management of small renal masses (SRM). Can Urol Assoc J 9(5–6):160–163
Mennitto A et al (2017) Multimodal treatment of advanced renal cancer in 2017. Expert Rev Clin Pharmacol 10(12):1395–1402
Klatte T et al (2011) Laparoscopic cryoablation versus partial nephrectomy for the treatment of small renal masses: systematic review and cumulative analysis of observational studies. Eur Urol 60(3):435–443
Mason RJ et al (2017) Renal functional outcomes in patients undergoing percutaneous cryoablation or partial nephrectomy for a solitary renal mass. BJU Int 120(4):544–549
Lai WJ et al (2015) Percutaneous computed tomography-guided cryoablation for renal tumor: experience in 30 cases. J Chin Med Assoc 78(5):308–315
Bhindi B et al (2018) Outcomes after cryoablation versus partial nephrectomy for sporadic renal tumors in a solitary kidney: a propensity score analysis. Eur Urol 73(2):254–259
Brashears JH 3rd et al (2005) Renal cryoablation and radio frequency ablation: an evaluation of worst case scenarios in a porcine model. J Urol 173(6):2160–2165
Allaf ME et al (2005) Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation-initial observations. Radiology 237(1):366–370
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213
Campbell SC et al (2009) Guideline for management of the clinical T1 renal mass. J Urol 182(4):1271–1279
Anderson CJ, Havranek EG (2004) Minimally invasive ablative techniques in renal cancer. BJU Int 93(6):707–709
Berger A et al (2008) Minimally invasive nephron-sparing surgery. Curr Opin Urol 18(5):462–466
Haramis G et al (2012) Retrospective comparison of laparoscopic partial nephrectomy versus laparoscopic renal cryoablation for small (< 3.5 cm) cortical renal masses. J Laparoendosc Adv Surg Tech A 22(2):152–157
Ahmad M et al (2017) Cryoablation of renal angiomyolipoma: an evaluation of safety and efficacy. J Endourol 31(11):1117–1122
Azevedo AAP et al (2018) Image-guided percutaneous renal cryoablation: five years experience, results and follow-up. Eur J Radiol 100:14–22
Kunkle DA, Uzzo RG (2008) Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 113(10):2671–2680
Hegarty NJ et al (2006) Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology 68(1 Suppl):7–13
Gage AA, Baust J (1998) Mechanisms of tissue injury in cryosurgery. Cryobiology 37(3):171–186
Zhuang J et al (2015) The application of PADUA scoring system for predicting complications of laparoscopic renal cryoablation. Int Urol Nephrol 47(5):781–788
Chiang PH, Su HH (2013) Randomized and prospective trial comparing tract creation using plasma vaporization with balloon dilatation in percutaneous nephrolithotomy. BJU Int 112(1):89–93
Hommos MS, Glassock RJ, Rule AD (2017) Structural and functional changes in human kidneys with healthy aging. J Am Soc Nephrol. https://doi.org/10.1681/ASN.2017040421
Denic A, Glassock RJ, Rule AD (2016) Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis 23(1):19–28
Aoun HD et al (2017) Percutaneous cryoablation of renal tumors: is it time for a new paradigm shift? J Vasc Interv Radiol 28(10):1363–1370
Tanagho YS et al (2013) Renal cryoablation versus robot-assisted partial nephrectomy: Washington university long-term experience. J Endourol 27(12):1477–1486
Gill IS et al (2005) Renal cryoablation: outcome at 3 years. J Urol 173(6):1903–1907
Aron M et al (2010) Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol 183(3):889–895
Finley DS et al (2008) Percutaneous and laparoscopic cryoablation of small renal masses. J Urol 180(2):492–498 discussion 498
Duffey B et al (2012) Intermediate-term outcomes after renal cryoablation: results of a multi-institutional study. J Endourol 26(1):15–20
Lehman DS et al (2008) First prize (tie): laparoscopic renal cryoablation: efficacy and complications for larger renal masses. J Endourol 22(6):1123–1127
Acknowledgements
We appreciate the Biostatistics Center at KCGMH for the statistics work. This manuscript was edited by Wallace Academic Editing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No financial conflicts of interest related to the subject matter or materials discussed in the manuscript.
Rights and permissions
About this article
Cite this article
Liu, HY., Shen, SH., Hsu, LN. et al. Comparisons of percutaneous versus retroperitoneoscopic cryoablation for renal masses. Int Urol Nephrol 50, 1407–1415 (2018). https://doi.org/10.1007/s11255-018-1925-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-018-1925-7